J. Pressacco

Modulation of the equilibrative nucleoside transporter by inhibitors of DNA synthesis.

D. Hedley, C. Erlichman, J. Wiley, 1995, British Journal of Cancer.

Biochemical effects of folate-based inhibitors of thymidylate synthase in MGH-U1 cells

C. Erlichman, S. Mandelbaum, J. Pressacco, 2004, Cancer Chemotherapy and Pharmacology.

Effects of thymidylate synthase inhibition on thymidine kinase activity and nucleoside transporter expression.

D. Hedley, C. Erlichman, J. Pressacco, 1995, Cancer research.

Combination studies with 3'-azido-3'-deoxythymidine (AZT) plus ICI D1694. Cytotoxic and biochemical effects.

C. Erlichman, J. Pressacco, 1993, Biochemical pharmacology.

Biochemical modulation of iododeoxyuridine by N6-[4-(morpholinosulfonyl)benzyl]-N6-methyl-2,6-diaminobenz[cd]indole glucuronate (AG-331) leading to enhanced cytotoxicity.

D. Hedley, C. Erlichman, J. Pressacco, 1995, Biochemical pharmacology.

Interactions of bupranolol with the polymorphic debrisoquine/sparteine monooxygenase (CYP2D6)

W. Kalow, J. Pressacco, R. Muller, 2004, European Journal of Clinical Pharmacology.

Cytotoxic and biochemical implications of combining AZT and AG-331

C. Erlichman, J. Pressacco, B. Mitrovski, 2009, Cancer Chemotherapy and Pharmacology.

ICI D1694 and idoxuridine: a synergistic antitumor combination.

D. Hedley, C. Erlichman, J. Pressacco, 1994, Cancer research.